Ethical capital: 'what's a poor man got to leave?'

Sociology of Health & Illness
Beverley WilliamsPatricia Drentea

Abstract

For those of little or no means, leaving one's mark through financial assets, social connections, and human investment is difficult. Using secondary analysis of transcripts from face-to-face interviews with 33 terminally-ill patients from an outpatient clinic at a public hospital serving the disadvantaged in the southern United States, we examine the legacy participants wish to leave behind. As part of this process, participants assess life circumstances to try and generate a legacy allowing them to remain personally relevant to loved ones after death. For the low-SES terminally ill persons in this study, the desire to leave a material legacy and the means to do so are not congruous. In the absence of economic resources to bequeath loved ones, participants describe their desire to leave loved ones some form of ethical currency to facilitate interactions with others and protect them against social marginalisation. We call this concept ethical capital. We then argue ethical capital is a way for disadvantaged people to find dignity and to affirm their lives.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jun 22, 1999·International Journal of Aging & Human Development·J Hendricks
Sep 15, 2000·International Journal of Aging & Human Development·M A GoettingC Johnson
Jan 18, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·UNKNOWN New York City Department of Health HIV Epidemiology Group
Feb 5, 2002·Social Science & Medicine·Harvey Max ChochinovMike Harlos
Apr 3, 2003·Qualitative Health Research·Barbara Johnson, Jill Macleod Clarke
Oct 8, 2003·Journal of Holistic Nursing : Official Journal of the American Holistic Nurses' Association·Jurate A Sakalys
Sep 9, 2004·Journal of Palliative Medicine·Charles E GessertIrina V Haller
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harvey Max ChochinovMike Harlos
Oct 6, 2005·Qualitative Health Research·Hsiu-Fang Hsieh, Sarah E Shannon
Apr 6, 2006·Palliative & Supportive Care·S Tziporah Cohen, Susan Block
Aug 3, 2006·Journal of Psychiatric Practice·Norman A Clemens
Aug 31, 2006·Journal of Pain and Symptom Management·Nessa Coyle
Nov 3, 2006·Physical Therapy·Ben F Massey
Dec 15, 2006·Holistic Nursing Practice·Susan M Hinck
Dec 21, 2006·Health & Social Work·Lucinda Lee RoffRichard M Allman
Jan 27, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Bruno Glaser
Aug 19, 2007·Critical Care Nursing Clinics of North America·Mary Fran Tracy, Kirsten Skillings
Nov 8, 2007·Journal of Palliative Medicine·Susan McClementMike Harlos
Sep 16, 2008·Journal of Palliative Medicine·Rebecca S AllenLouis D Burgio
Sep 25, 2008·BMJ : British Medical Journal·Nicholas A Christakis
Feb 3, 2009·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Helen K Black, Robert L Rubinstein

❮ Previous
Next ❯

Citations

Apr 21, 2017·The American Journal of Hospice & Palliative Care·Eric W AndersonSandra E Schellinger
Jul 1, 2017·The American Journal of Hospice & Palliative Care·Eric W Anderson, Katie M White

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.